Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Eur J Nucl Med Mol Imaging. 2024 Dec;52(1):335-341. doi: 10.1007/s00259-024-06857-w. Epub 2024 Aug 15.
Accurate diagnosis and staging of prostate cancer are crucial to improving patient care. Prostate-specific membrane antigen (PSMA)-targeted positron emission tomography with computed tomography (PET/CT) imaging has demonstrated superiority for initial staging and restaging in patients with prostate cancer. Referring physicians and PET/CT readers must agree on a consistent communication method and application of information derived from this imaging modality. While several guidelines have been published, a single PSMA PET/CT reporting template has yet to be widely adopted. Based on the consensus from community and academic physicians, we developed a standardized PSMA PET/CT reporting template for radiologists and nuclear medicine physicians to report and relay key imaging findings to referring physicians. The aim was to improve the quality, clarity, and utility of imaging results reporting to facilitate patient management decisions.
Based on community and expert consensus, we developed a standardized PSMA PET/CT reporting template to deliver key imaging findings to referring clinicians.
Core category components proposed include a summary of any prior treatment history; presence, location, and degree of PSMA radiopharmaceutical uptake in primary and/or metastatic tumor(s), lesions with no uptake, and incidentally found lesions with positive uptake on PET/CT.
This article provides recommendations on best practices for standardized reporting of PSMA PET/CT imaging. The generated reporting template is a proposed supplement designed to educate and improve data communication between imaging experts and referring physicians.
准确诊断和分期前列腺癌对于改善患者治疗至关重要。前列腺特异性膜抗原（PSMA）靶向正电子发射断层扫描与计算机断层扫描（PET/CT）成像已被证明在前列腺癌患者的初始分期和再分期方面具有优越性。转诊医生和 PET/CT 读者必须就一致的沟通方法和从这种成像方式获得的信息的应用达成一致。尽管已经发布了几项指南，但尚未广泛采用单一的 PSMA PET/CT 报告模板。基于社区和学术医生的共识，我们为放射科医生和核医学医生开发了一个标准化的 PSMA PET/CT 报告模板，以报告和向转诊医生传达关键的成像发现。目的是提高成像结果报告的质量、清晰度和实用性，以促进患者管理决策。
基于社区和专家共识，我们开发了一个标准化的 PSMA PET/CT 报告模板，将关键的成像发现传递给转诊临床医生。
提出的核心类别组件包括任何既往治疗史的总结；原发和/或转移性肿瘤（s）、无摄取的病变以及 PET/CT 上偶然发现的摄取阳性的病变中 PSMA 放射性药物摄取的存在、位置和程度。
本文就 PSMA PET/CT 成像的标准化报告提供了最佳实践建议。生成的报告模板是一个补充建议，旨在教育和改善成像专家和转诊医生之间的数据沟通。
